Matches in SemOpenAlex for { <https://semopenalex.org/work/W2088013635> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W2088013635 endingPage "373" @default.
- W2088013635 startingPage "369" @default.
- W2088013635 abstract "Objective: Despite the rapid spread of human immunodeficiency virus (HIV) in the developing countries of Africa, Asia and Latin America, accessible and affordable antiretroviral therapies have not been developed. Dinitrochlorobenzene (DNCB) is an inexpensive contact sensitizing agent that stimulates cell-mediated immunity when applied to the skin. We have examined the clinical and immunologic effects of topical DNCB therapy in a cohort of indigent patients with HIV disease from Brazil. Design and Methods: Thirty-five HIV-infected subjects were divided into a control group that refused DNCB therapy (6 patients) and a treatment group that applied topical DNCB on a weekly basis throughout the study (29 patients). Subjects were monitored for adverse clinical events, progression to AIDS and changes in body weight. CD4 and CD8 T-cell counts were also monitored in both groups. Results: Control and treated patients were evenly matched in terms of age, initial clinical status and prior adverse clinical events. The mean follow-up was 19.7 months for the control group and 17.8 months for the DNCB group. Control patients had significantly more adverse clinical events and progression to AIDS during the study than the treatment group (p = 0.002 and p = 0.013, respectively). There were no deaths in either group. Control patient weights decreased over the study period while DNCB patient weights increased (p < 0.001). CD4 and CD8 T-cell counts decreased significantly in the control group and increased in the DNCB group (p < 0.001 and p = 0.031, respectively). DNCB therapy was well tolerated. Conclusions: Topical DNCB therapy affords a rational, effective and inexpensive treatment approach for HIV disease. DNCB should benefit patients in developing nations with limited access to health care." @default.
- W2088013635 created "2016-06-24" @default.
- W2088013635 creator A5007035195 @default.
- W2088013635 creator A5015159159 @default.
- W2088013635 creator A5023045894 @default.
- W2088013635 date "1997-01-01" @default.
- W2088013635 modified "2023-09-26" @default.
- W2088013635 title "Topical Immune Modulation with Dinitrochlorobenzene in HIV Disease: A Controlled Trial from Brazil" @default.
- W2088013635 doi "https://doi.org/10.1159/000245990" @default.
- W2088013635 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9529559" @default.
- W2088013635 hasPublicationYear "1997" @default.
- W2088013635 type Work @default.
- W2088013635 sameAs 2088013635 @default.
- W2088013635 citedByCount "17" @default.
- W2088013635 countsByYear W20880136352012 @default.
- W2088013635 countsByYear W20880136352013 @default.
- W2088013635 countsByYear W20880136352017 @default.
- W2088013635 countsByYear W20880136352018 @default.
- W2088013635 crossrefType "journal-article" @default.
- W2088013635 hasAuthorship W2088013635A5007035195 @default.
- W2088013635 hasAuthorship W2088013635A5015159159 @default.
- W2088013635 hasAuthorship W2088013635A5023045894 @default.
- W2088013635 hasConcept C126322002 @default.
- W2088013635 hasConcept C141071460 @default.
- W2088013635 hasConcept C167672396 @default.
- W2088013635 hasConcept C197934379 @default.
- W2088013635 hasConcept C203014093 @default.
- W2088013635 hasConcept C2780648854 @default.
- W2088013635 hasConcept C3017875465 @default.
- W2088013635 hasConcept C535046627 @default.
- W2088013635 hasConcept C71924100 @default.
- W2088013635 hasConcept C72563966 @default.
- W2088013635 hasConcept C8891405 @default.
- W2088013635 hasConcept C90924648 @default.
- W2088013635 hasConceptScore W2088013635C126322002 @default.
- W2088013635 hasConceptScore W2088013635C141071460 @default.
- W2088013635 hasConceptScore W2088013635C167672396 @default.
- W2088013635 hasConceptScore W2088013635C197934379 @default.
- W2088013635 hasConceptScore W2088013635C203014093 @default.
- W2088013635 hasConceptScore W2088013635C2780648854 @default.
- W2088013635 hasConceptScore W2088013635C3017875465 @default.
- W2088013635 hasConceptScore W2088013635C535046627 @default.
- W2088013635 hasConceptScore W2088013635C71924100 @default.
- W2088013635 hasConceptScore W2088013635C72563966 @default.
- W2088013635 hasConceptScore W2088013635C8891405 @default.
- W2088013635 hasConceptScore W2088013635C90924648 @default.
- W2088013635 hasIssue "4" @default.
- W2088013635 hasLocation W20880136351 @default.
- W2088013635 hasLocation W20880136352 @default.
- W2088013635 hasOpenAccess W2088013635 @default.
- W2088013635 hasPrimaryLocation W20880136351 @default.
- W2088013635 hasRelatedWork W2014564023 @default.
- W2088013635 hasRelatedWork W2031253481 @default.
- W2088013635 hasRelatedWork W2044516747 @default.
- W2088013635 hasRelatedWork W2050374169 @default.
- W2088013635 hasRelatedWork W2074583709 @default.
- W2088013635 hasRelatedWork W2078394626 @default.
- W2088013635 hasRelatedWork W2109406522 @default.
- W2088013635 hasRelatedWork W2265125857 @default.
- W2088013635 hasRelatedWork W4310108204 @default.
- W2088013635 hasRelatedWork W72085878 @default.
- W2088013635 hasVolume "195" @default.
- W2088013635 isParatext "false" @default.
- W2088013635 isRetracted "false" @default.
- W2088013635 magId "2088013635" @default.
- W2088013635 workType "article" @default.